<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/eurofins-sf-analytical-laboratories-fda-warning-letter-microbial-data-integrity-2026</loc>
    <lastmod>2026-10-13T21:50:56+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Eurofins SF Analytical Laboratories Receives FDA Warning Letter for Microbial Data Integrity Failures at Horsham Facility</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/997775e7-f6f8-47c3-814d-71853d1250c3/c0582146-b290-4735-ac70-357da9be2848.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lovelace-biomedical-fda-warning-letter-glp-raw-data-reconciliation-2026</loc>
    <lastmod>2026-10-13T22:05:05+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Lovelace Biomedical Receives FDA Warning Letter Over GLP Raw Data Reconciliation Failures</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/997775e7-f6f8-47c3-814d-71853d1250c3/3ba7cfdd-c23d-4593-9850-3e7d7acad6d3.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/hanlim-pharm-fda-warning-letter-aseptic-failures-sterile-fill-finish-2026</loc>
    <lastmod>2026-10-13T22:02:43+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Hanlim Pharm Receives FDA Warning Letter After Aseptic Failures Found at Sterile Fill-Finish Facility</news:title>
      <news:keywords>Hanlim Pharm FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/997775e7-f6f8-47c3-814d-71853d1250c3/41c00a23-d5ce-4186-b50f-7daa9d538f38.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sca-pharmaceuticals-fda-warning-letter-503b-sterile-compounding-cgmp-2026</loc>
    <lastmod>2026-10-13T21:51:57+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>SCA Pharmaceuticals Receives FDA Warning Letter Citing Sterile Compounding CGMP Failures at 503B Facility</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/997775e7-f6f8-47c3-814d-71853d1250c3/e630172a-0dd5-4bbb-8955-7ae8f1a2f798.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/bristol-myers-squibb-ryz101-phase-3-primary-endpoint-neuroendocrine-cancer</loc>
    <lastmod>2026-10-13T21:55:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Bristol Myers Squibb’s RYZ101 Meets Phase 3 Endpoint in GEP-NETs</news:title>
      <news:keywords>BMS RYZ101</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2fb65f15-33b1-40b5-b55a-29d531082bc5/2df06a9e-80ca-4192-84ba-645aaaafcf30.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/phio-pharmaceuticals-completes-first-commercial-scale-cgmp-batch-ph-762</loc>
    <lastmod>2026-10-13T21:55:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Phio Pharmaceuticals Completes First Commercial-Scale cGMP Batch of PH-762 Drug Substance Ahead of Phase 2b</news:title>
      <news:keywords>Phio Pharmaceuticals</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2fb65f15-33b1-40b5-b55a-29d531082bc5/a1fe61ff-a339-4928-bdfb-1355c1fa895e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lonza-qurient-exclusive-deal-dual-payload-adc-cancer-therapies</loc>
    <lastmod>2026-10-13T22:00:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Lonza Signs Exclusive Deal with Qurient to Advance Dual-Payload ADC Cancer Therapies</news:title>
      <news:keywords>Lonza-Qurient</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2fb65f15-33b1-40b5-b55a-29d531082bc5/a30f4e18-a3bc-493c-bb44-d5ac7352d970.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development</loc>
    <lastmod>2026-10-13T21:59:29+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Perceptive Discovery Partners With Nucleus RadioPharma, Accelerate Radiopharmaceutical Development</news:title>
      <news:keywords>Perceptive</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2fb65f15-33b1-40b5-b55a-29d531082bc5/c521bf5e-45b2-4df0-845e-c951760a5c9d.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review</loc>
    <lastmod>2026-10-13T21:50:32+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00+05:30</news:publication_date>
      <news:title>Zydus and Formycon Secure FDA Acceptance for First Pembrolizumab Biosimilar</news:title>
      <news:keywords>Zydus &amp; Formycon</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8590a428-5eb2-4b53-9b39-f8f4ebd134c0/7009d6e0-73c7-470a-8175-5e6198a37bb3.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations</loc>
    <lastmod>2026-10-13T11:26:29+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T00:00:00+05:30</news:publication_date>
      <news:title>Dr. Reddy's FTO-11 Plant Receives Two FDA Form 483 Observations After Andhra Pradesh Inspection</news:title>
      <news:keywords>Dr. Reddy's</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations-202620261013112445.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cadila-pharmaceuticals-appoints-nirav-gandhi-president</loc>
    <lastmod>2026-10-13T11:15:53+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T00:00:00+05:30</news:publication_date>
      <news:title>Cadila Pharmaceuticals Appoints Nirav Gandhi as President Amid US Market Push</news:title>
      <news:keywords>Cadila</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cadila-pharmaceuticals-nirav-gandhi-president-202620261013111539.webp</image:loc>
    </image:image>
  </url>
</urlset>